Margaret Dalesandro

Margaret Dalesandro

Gründer bei
Brecon Pharma Consulting LLC
79 Jahre
Health Technology
Consumer Services
Electronic Technology

Profil

Margaret R.
Dalesandro
is the founder of Brecon Pharma Consulting LLC, founded in 2012, serving as President.
Current jobs include Director at Emerald Health Bioceuticals, Inc. since 2020 and Independent Director at Ambrx Biopharma Cayman, Inc. since 2023.
Former jobs include Director-Immunobiology & Diagnostic Research at Centocor, Inc. from 1989 to 1998; Business Director-Integrative Pharmacology at Corning, Inc. from 2009 to 2012; Independent Director at OncoSec Medical, Inc. from 2019 to 2020; Executive Director-Project & Portfolio Management at GSK Plc from 2000 to 2002; Independent Director at Ambrx Biopharma Cayman, Inc. from 2023 to 2024; Independent Director at Skye Bioscience, Inc. from 2020 to 2024; Independent Director at Seelos Therapeutics, Inc. from 2021 to 2024; and VP-Project, Portfolio & Alliance Management at ImClone LLC from 2002 to 2009.
Education includes graduate and doctorate degrees from Bryn Mawr College and an undergraduate degree from Rosemont College.

Aktive Positionen von Margaret Dalesandro

UnternehmenPositionBeginn
Brecon Pharma Consulting LLC
Gründer 01.09.2012
Direktor/Vorstandsmitglied 01.02.2020
Direktor/Vorstandsmitglied 01.09.2023

Ehemalige bekannte Positionen von Margaret Dalesandro

UnternehmenPositionEnde
SEELOS THERAPEUTICS, INC. Direktor/Vorstandsmitglied 16.10.2024
SKYE BIOSCIENCE, INC. Direktor/Vorstandsmitglied 01.08.2024
Direktor/Vorstandsmitglied 07.03.2024
ONCOSEC MEDICAL INCORPORATED Vorstandsvorsitzender 13.12.2021
CORNING INCORPORATED Corporate Officer/Principal 01.01.2012
Sehen Sie sich die Erfahrung von Margaret Dalesandro im Detail an

Ausbildung von Margaret Dalesandro

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Brecon Pharma Consulting LLC

Health Technology

  1. Börse
  2. Insiders
  3. Margaret Dalesandro
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT